Previous Next

REFERENCES

451. Chen ST, Hsu CY, Hogan EL, et al: Thromboxane, prostacyclin, and leukotrienes in cerebral ischemia. Neurology 36:466–470, 1986.

452. Pieper AA, Verma A, Zhang J, Snyder SH: Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171–181, 1999.

453. Marsh WR, Anderson RE, Sundt TM: Effect of hyperglycemia on brain pH levels in areas of focal incomplete cerebral ischemia in monkeys. J Neurosurg 65:693–696, 1986.

454. Chopp M, Welch KMA, Tidwell CD, Helpern JA: Global cerebral ischemia and intracellular pH during hyperglycemia and hypoglycemia in cats. Stroke 19:1383–1387, 1988.

455. Smith M-L, vonHanwehr R, Seisjo BK: Changes in extra- and intracellular pH in the brain during and following ischemia in hyperglycemic and moderately hypoglycemic rats. J Cereb Blood Flow Metab 6:574–583, 1986.

456. Folbergrová J, Memezawa H, Smith M-L, Siesjö BK: Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab 12:25–33, 1992.

457. Dawson TM, Dawson VL, Snyder SH: A novel neuronal messenger molecule in brain: The free radical, nitric oxide. Ann Neurol 32:297–311, 1992.

458. Beckman JS: The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J Dev Physiol 15:53–59, 1991.

459. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 20:132–139, 1997.

460. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 28:1283–1288, 1997.

461. Lipton P: Ischemic cell death in brain neurons. Physiol Rev 79:1431–1568, 1999.

462. Fiskum G, Murphy AN, Beal MF: Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases. J Cereb Blood Flow Metab 19:351–369, 1999.

463. Hou ST, MacManus JP: Molecular mechanisms of cerebral ischemia-induced neuronal death. Int Rev Cytol 221:93–148, 2002.

464. Velier JJ, Ellison JA, Kikly KK, et al: Caspase-8 and caspase-3 are expressed by different populations of cortical neurons undergoing delayed cell death after focal stroke in the rat. J Neurosci 19:5932–5941, 1999.

465. Kawaguchi M, Kimbro JR, Drummond JC, et al: Isoflurane delays but does not prevent cerebral infarction in rats subjected to focal ischemia. Anesthesiology 92:1335–1342, 2000.

466. Du C, Hu R, Csernansky C, et al: Very delayed infarction after mild focal cerebral ischemia: A role for apoptosis? J Cereb Blood Flow Metab 16:195–201, 1996.

467. Dirnagl U, Iadecola C, Moskowitz M: Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22:391–397, 1999.

468. Zauner A, Daugherty WP, Bullock MR, Warner DS: Brain oxygenation and energy metabolism: Part I—biological function and pathophysiology. Neurosurgery 51:289–301, 2002.

469. Graham S, Chen J: Programmed cell death in cerebral ischemia. J Cereb Blood Flow Metab 21:99–109, 2001.

470. Chan PH: Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 21:2–14, 2001.

471. Mattson MP, Duan W, Pedersen WA, Culmsee C: Neurodegenerative disorders and ischemic brain diseases. Apoptosis 6:69–81, 2001.

472. Abramson NA: Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 314:397–403, 1986.

473. Todd MM, Chadwich HC, Shapiro HM, et al: The neurologic effects of thiopental therapy following cardiac arrest in cats. Anesthesiology 57:76–86, 1982.

474. Gisvold SE, Safar P, Hendrickx HHL, et al: Thiopental treatment after global ischemia in pig-tailed monkeys. Anesthesiology 60:88–96, 1984.

475. Steen PA, Gisvold SE, Milde JH, et al: Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 62:406–414, 1985.

476. Tateishi A, Fleischer JE, Drummond JC, et al: Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats. Stroke 20:1044–1050, 1989.

477. Tateishi A, Scheller MS, Drummond JC, et al: Failure of nimodipine to improve neurologic outcome after eighteen minutes of cardiac arrest in the cat. Resuscitation 211:191–206, 1991.

478. Steen PA, Newberg LA, Milde JH, Michenfelder JD: Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 4:82–87, 1984.

479. Forsman M, Aarseth HP, Nordby HK, et al: Effects of nimodipine on cerebral blood flow and cerebrospinal fluid pressure after cardiac arrest: Correlation with neurologic outcome. Anesth Analg 68:436–443, 1989.

480. Roine RO, Kaste M, Kinnunen A, et al: Nimodipine after resuscitation from out-of-hospital ventricular fibrillation: A placebo-controlled, double-blind, randomized trial. JAMA 264:3171–3177, 1990.

481. Lidoflazine: Brain Resuscitation Clinical Trial II Study Group. A randomized clinical study of a calcium-entry blocker (Lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med 324:1225–1231, 1991.


855


482. Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346:549–556, 2002.

483. Hoffman WE, Cheng MA, Thomas C, et al: Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg 73:460–464, 1991.

484. Hoffman WE, Thomas C, Albrecht RF: The effect of halothane and isoflurane on neurologic outcome following incomplete cerebral ischemia in the rat. Anesth Analg 76:279–283, 1993.

485. Smith AL, Hoff JT, Nielsen SL, Larson CP: Barbiturate protection in acute focal cerebral ischemia. Stroke 5:1–7, 1974.

486. Hoff JT, Smith AL, Hankinson HL, Nielsen SL: Barbiturate protection from cerebral infarction in primates. Stroke 6:28–33, 1975.

487. Michenfelder JD, Milde JH, Sundt TM: Cerebral protection by barbiturate anesthesia. Use after middle cerebral artery occlusion in Java monkeys. Arch Neurol 33:345–350, 1976.

488. Lawner PM, Laurent JP, Simeone FA, Fink EA: Effect of extracranial-intracranial bypass and pentobarbital on acute stroke in dogs. J Neurosurg 56:92–96, 1982.

489. Selman WR, Spetzler RF, Roski RA, et al: Barbiturate coma in focal cerebral ischemia. Relationship of protection to timing of therapy. J Neurosurg 56:685–690, 1982.

490. Hoff JT, Nishimura M, Newfield P: Pentobarbital protection from cerebral infarction without suppression of edema. Stroke 13:623–628, 1982.

491. Nehls DG, Todd MM, Spetzler RF, et al: A comparison of the cerebral protective effects of isoflurane and barbiturates during temporary focal ischemia in primates. Anesthesiology 66:453–464, 1987.

492. Nussmeier NA, Arlund C, Slogoff S: Neuropsychiatric complications after cardiopulmonary bypass: Cerebral protection by a barbiturate. Anesthesiology 64:165–170, 1986.

493. Shapiro HM: Barbiturates in brain ischemia. Br J Anaesth 57:82–95, 1985.

494. Todd MM, Warner DS: A comfortable hypothesis re-evaluated: Cerebral metabolic rate depression and brain protection during ischemia [editorial]. Anesthesiology 76:161–164, 1992.

495. Nakashima K, Todd MM, Warner DS: The relation between cerebral metabolic rate and ischemic depolarization. Anesthesiology 82:1199–1208, 1995.

496. Warner DS, Takaoka S, Wu B, et al: Electroencephalographic burst suppression is not required to elicit maximal neuroprotection from pentobarbital in a rat model of focal cerebral ischemia. Anesthesiology 84:1475–1484, 1996.

497. Busto R, Dietrich WD, Globus MY-T, et al: Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury. J Cereb Blood Flow Metab 7:729–738, 1987.

498. Sano T, Drummond JC, Patel PM, et al: A comparison of the cerebral protective effects of isoflurane and mild hypothermia in a model of incomplete forebrain ischemia in the rat. Anesthesiology 76:221–228, 1992.

499. Buchan A, Pulsinelli WA: Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10:311–316, 1990.

500. Warner DS, Zhou J, Ramani R, Todd MM: Reversible focal ischemia in the rat: Effects of halothane, isoflurane, and methohexital anesthesia. J Cereb Blood Flow Metab 11:794–802, 1991.

501. Drummond JC, Cole DJ, Patel PM, Reynolds LW: Focal cerebral ischemia during anesthesia with etomidate, isoflurane or thiopental: A comparison of the extent of cerebral injury. Neurosurgery 37:742–749, 1995.

502. Gisvold SE, Safar P, Hendrick HHL, et al: Thiopental treatment after global brain ischemia in pigtailed monkeys. Anesthesiology 60:88–96, 1984.

503. Cole DJ, Cross LM, Drummond JC, et al: Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth 48:807–814, 2001.

504. Baughman VL, Hoffman WE, Miletich DJ, et al: Neurologic outcome in rats following incomplete cerebral ischemia during halothane, isoflurane or N2 O. Anesthesiology 69:192–198, 1988.

505. Soonthan-Brant V, Patel PM, Drummond JC, et al: Fentanyl does not increase brain injury after focal cerebral ischemia in rats. Anesth Analg 88:49–55, 1999.

506. Mackensen GB, Nellgard B, Kudo M, et al: Peri-ischemic cerebral blood flow (CBF) does not explain beneficial effects of isoflurane on outcome from near complete forebrain ischemia in rats. Anesthesiology 93:1102–1106, 2000.

507. Nellgard B, Mackensen GB, Pineda J, et al: Anesthetic effects on cerebral metabolic rate predict histologic outcome from near-complete forebrain ischemia in the rat. Anesthesiology 93:431–436, 2000.

508. Kawaguchi M, Kimbro JR, Drummond JC, et al: Effects of isoflurane on neuronal apoptosis in rats subjected to focal ischemia. J Neurosurg Anesthesiol 12:385, 2000.

509. Warner DS, Desphande JK, Wieloch T: The effect of isoflurane on neuronal necrosis following near-complete forebrain ischemia in the rat. Anesthesiology 64:19–23, 1986.

510. Baughman VL, Hoffman WE, Miletich DJ, et al: Neurologic outcome in rats following incomplete cerebral ischemia during halothane, isoflurane, or N2 O. Anesthesiology 69:192–198, 1988.

511. Milde LN, Milde JH, Lanier WL, et al: Comparison of the effects of isoflurane and thiopental on neurologic outcome and neuropathology after temporary focal cerebral ischemia in primates. Anesthesiology 69:905–913, 1988.

512. Gelb AW, Boisvert DP, Tang C, et al: Primate brain tolerance to temporary focal cerebral ischemia during isoflurane- or sodium nitroprusside-induced hypotension. Anesthesiology 70:678–683, 1989.

513. Ruta TS, Drummond JC, Cole DJ: A comparison of the area of histochemical dysfunction after focal cerebral ischaemia during anaesthesia with isoflurane and halothane in the rat. Can J Anaesth 38:129–135, 1991.

514. Warner DS, Todd MM, McFarlane C, et al: Sevoflurane and halothane reduce focal ischemic brain damage in the rat: Possible influence on thermoregulation. Anesthesiology 79:985–992, 1993.

515. Warner DS, McFarlane C, Todd MM, et al: Sevoflurane and halothane reduce focal ischemic brain damage in the rat. Anesthesiology 79:985–992, 1993.

516. Werner C, Mollenberg O, Kochs E, Schulte JE: Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaesth 75:756–760, 1995.

517. Engelhard K, Werner C, Reeker W, et al: Desflurane and isoflurane improve neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaesth 83:415–421, 1999.

518. Ravussin P, deTribolet N: Total intravenous anesthesia with propofol for burst suppression in cerebral aneurysm surgery: Preliminary report of 42 patients. Neurosurgery 32:236–240, 1993.

519. Ridenour TR, Warner DS, Todd MM, Glonet TX: Comparative effects of propofol and halothane on outcome from temporary middle cerebral artery occlusion in the rat. Anesthesiology 76:807–812, 1992.

520. Gelb AW, Bayona NA, Wilson JX, Cechetto DF: Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 96:1183–1190, 2002.

521. Pittman JE, Sheng H, Pearlstein RD, et al: Comparison of the effects of propofol and pentobarbital on neurologic outcome and cerebral infarction size after temporary focal ischemia in the rat. Anesthesiology 87:1139–1144, 1997.

522. Batjer HH, Frankfurt AI, Purdy PD, et al: Use of etomidate, temporary arterial occlusion, and intraoperative angiography in surgical treatment of large and giant cerebral aneurysms. J Neurosurg 68:234–240, 1988.

523. Watson JC, Drummond JC, Patel PM, et al: An assessment of the cerebral protective effects of etomidate in a model of incomplete forebrain ischemia in the rat. Neurosurgery 30:540–544, 1992.
856


524. Sano T, Patel PM, Drummond JC, Cole DJ: A comparison of the cerebral protective effects of etomidate, thiopental and isoflurane in a model of forebrain ischemia in the rat. Anesth Analg 76:990–997, 1993.

525. McKay L, Drummond JC, Cole DJ, et al: Effect of nitric oxide on focal cerebral ischemic injury during etomidate or halothane anesthesia in rats [abstract]. Anesthesiology 85:A1181, 1996.

526. Nebauer AE, Doenicke A, Hoernecke R, et al: Does etomidate cause haemolysis? Br J Anaesth 69:58–60, 1992.

527. Wolff DJ, Datto GA, Samatovicz RA, Tempsick RA: Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem 268:9425–9429, 1993.

528. Samson D, Batjer HH, Bowman G, et al: A clinical study of the parameters and effects of temporary arterial occlusion in the management of intracranial aneurysms. Neurosurgery 34:22–28, discussion 28–29, 1994.

529. Pickard JD, Murray GD, Illingworth R, et al: Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British Aneurysm Nimodipine Trial. BMJ 298:636–642, 1989.

530. Gelmers HJ, Gorter K, DeWeerdt CJ, Wiezer HJA: A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med 318:203–207, 1988.

531. Rosenbaum D, Zabramski J, Frey J, et al: Early treatment of ischemic stroke with a calcium antagonist. Stroke 22:437–441, 1991.

532. Trust Study Group: Randomised, double-blind, placebocontrolled trial of nimodipine in acute stroke. Lancet 336:1205–1209, 1990.

533. Wise G, Sutter R, Burkholder J: The treatment of brain ischemia with vasopressor drugs. Stroke 3:135–140, 1972.

534. Cole DJ, Drummond JC, Osborne TN, Matsumura J: Hypertension and hemodilution during cerebral ischemia reduce brain injury and edema. Am J Physiol 259:H211–H217, 1990.

535. Young WL, Solomon RA, Pedley TA, et al: Direct cortical EEG monitoring during temporary vascular occlusion for cerebral aneurysm surgery. Anesthesiology 71:794–799, 1989.

536. Soloway M, Nadel W, Albin MS, White RJ: The effect of hyperventilation on subsequent cerebral infarction. Anesthesiology 29:975–980, 1968.

537. Waltz AG, Sundt TM, Michenfelder JD: Cerebral blood flow during carotid endarterectomy. Circulation 45:1091–1096, 1972.

538. Christensen MS, Paulson OB, Olesen J, et al: Cerebral apoplexy (stroke) treated with or without prolonged artificial hyperventilation: 1. Cerebral circulation, clinical course, and cause of death. Stroke 4:568–619, 1973.

539. Michenfelder JD, Sundt TM: The effect of PaCO2 on the metabolism of ischemic brain in squirrel monkeys. Anesthesiology 38:445–453, 1973.

540. Michenfelder JD, Milde JH: Failure of prolonged hypocapnia, hypothermia, or hypertension to favorably alter acute stroke in primates. Stroke 8:87–91, 1977.

541. Ruta TS, Drummond JC, Cole DJ: The effect of acute hypocapnia on local cerebral blood flow during middle cerebral artery occlusion in isoflurane anesthetized rats. Anesthesiology 78:134–140, 1993.

542. Busto R, Globus MY-T, Dietrich WD, et al: Effect of mild hypothermia on ischemia-induced release of neurotransmitters and free fatty acids in rat brain. Stroke 20:904–910, 1989.

543. Minamisawa H, Smith M-L, Siesjö BK: The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol 28:26–33, 1990.

544. Welsh FA, Sims RE, Harris VA: Mild hypothermia prevents ischemic injury in gerbil hippocampus. J Cereb Blood Flow Metab 10:557–563, 1990.

545. Ridenour TR, Warner DS, Todd MM, McAllister AC: Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats. Stroke 23:733–738, 1992.

546. Boris-Möller F, Smith M-L, Siesjö BK: Effects of hypothermia on ischemic brain damage: A comparison between preischemic and postischemia cooling. Neurosci Res Commun 5:87–94, 1989.

547. Busto R, Dietrich WD, Globus MY-T, Ginsberg MD: Post-ischemic moderate hypothermia inhibits CA1 hippocampal neuronal ischemic injury. Neurosci Lett 101:299–304, 1989.

548. Baker CJ, Onesti MT, Solomon RA: Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: A time-course study. J Neurosurg 77:438–444, 1992.

549. Coimbra C, Drake M, Boris-Moller F, Wieloch T: Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug. Evidence for chronic encephalopathic processes after ischemia. Stroke 27:1578–1585, 1996.

550. Ginsberg MD, Sternau LL, Globus MY-T, et al: Therapeutic modulation of brain temperature: Relevance to ischemic brain injury. Cerebrovasc Brain Metab Rev 4:189–225, 1992.

551. Hindman BJ, Todd MM, Gelb AW, et al: Mild hypothermia as a protective therapy during intracranial aneurysm surgery: A randomized prospective pilot trial. Neurosurgery 44:23–32, discussion 32–33, 1999.

552. Steiner T, Friede T, Aschoff A, et al: Effect and feasibility of controlled rewarming after moderate hypothermia in stroke patients with malignant infarction of the middle cerebral artery. Stroke 32:2833–2835, 2001.

553. Georgiadis D, Schwarz S, Kollmar R, Schwab S: Endovascular cooling for moderate hypothermia in patients with acute stroke. Stroke 32:2550–2553, 2001.

554. Krieger DW, DeGeorgia MA, Abou-Chebl A, et al: Cooling for acute ischemic brain damage (COOL AID). Stroke 32:1847–1854, 2001.

555. Schwab S, Georgiadis D, Berrouschot J, et al: Feasibility and safety of moderate hypothermia after massive hemispheric infarction. Stroke 32:2033–2035, 2001.

556. Kammersgaard LP, Rasmussen BH, Jorgensen HS, et al: Feasibility and safety of inducing modest hypothermia in awake patients with acute stroke through surface cooling: A case-control study. Stroke 31:2251–2256, 2000.

557. Bouma GJ, Muizelaar JP, Choi SC, et al: Cerebral circulation and metabolism after severe traumatic brain injury: The elusive role of ischemia. J Neurosurg 75:685–693, 1991.

558. Graham DI, Ford I, Adams JH, et al: Ischaemic brain damage is still common in fatal non-missile head injury. J Neurol Neurosurg Psychiatry 52:346–350, 1989.

559. Marion DW, Obrist WD, Carlier PM, et al: The use of moderate therapeutic hypothermia for patients with severe head injuries: A preliminary report. J Neurosurg 79:354–362, 1993.

560. Shiozaki T, Sugimoto H, Taneda M, et al: Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg 79:363–368, 1993.

561. Clifton GL, Allen S, Barrodale P, et al: A phase II study of moderate hypothermia in severe brain injury. J Neurotrauma 10:263–273, 1993.

562. Metz C, Holzschuh M, Bein T, et al: Moderate hypothermia in patients with severe head injury: Cerebral and extracerebral effects. J Neurosurg 85:533–541, 1996.

563. Clifton GL, Miller ET, Choi SC, et al: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 344:556–563, 2001.

564. Kuroiwa T, Bonnekoh P, Hossmann KA: Prevention of postischemic hyperthermia prevents ischemic injury of CA1 neurons in gerbils. J Cereb Blood Flow Metab 10:550–556, 1990.

565. Baena RC, Busto R, Dietrich WD, et al: Hyperthermia delayed by 24 hours aggravates neuronal damage in rat hippocampus following global ischemia. Neurology 48:768–773, 1997.

566. Pulsinelli WA, Waldman S, Rawlinson D, Plum F: Moderate hyperglycemia augments ischemic brain damage: A neuropathologic study in the rat. Neurology 32:1239–1246, 1982.
857


567. Lanier WL, Stangland KJ, Scheithauer BW, et al: The effects of dextrose infusion and head position on neurologic outcome after complete cerebral ischemia in primates: Examination of a model. Anesthesiology 66:39–48, 1987.

568. Drummond JC, Moore SS: The influence of dextrose administration on neurologic outcome after temporary spinal cord ischemia in the rabbit. Anesthesiology 70:64–70, 1989.

569. Nakakimura K, Fleischer JE, Drummond JC, et al: Glucose administration prior to cardiac arrest significantly worsens neurologic outcome in cats. Anesthesiology 72:1005–1011, 1990.

570. Vannucci RC, Brucklacher RM, Vannucci SJ: The effect of hyperglycemia on cerebral metabolism during hypoxiaischemia in the immature rat. J Cereb Blood Flow Metab 16:1026–1033, 1996.

571. Müllner M, Sterz F, Binder M, et al: Blood glucose concentration after cardiopulmonary resuscitation influences functional neurological recovery in human cardiac arrest survivors. J Cereb Blood Flow Metab 17:430–436, 1997.

572. Weir CJ, Murray GD, Dyker AG, Lees KR: Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 314:1303–1306, 1997.

573. Longstreth WT, Diehr P, Cobb LA, et al: Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation. Neurology 36:1186–1191, 1986.

574. Woo J, Lam CWK, Kay R, et al: The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch Neurol 47:1174–1177, 1990.

575. Frasco P, Croughwell N, Blumenthal J, et al: Association between blood glucose level during cardiopulmonary bypass and neuropsychiatric outcome [abstract]. Anesthesiology 75:A55, 1991.

576. Toni D, Sacchetti ML, Argentino C, et al: Does hyperglycaemia play a role on the outcome of acute ischaemic stroke patients? J Neurol 239:382–386, 1992.

577. Matchar DB, Divine GW, Heyman A, Feussner JR: The influence of hyperglycemia on outcome of cerebral infarction. Ann Intern Med 117:449–456, 1992.

578. Archer DP: The role of bloodletting in the prevention and treatment of asthenic apoplexy. J Neurosurg Anesthesiol 6:51–53, 1994.

579. Lenzi GL, Frackowiak RSJ, Jones T: Cerebral oxygen metabolism and blood flow in human cerebral ischemic infarction. J Cereb Blood Flow Metab 2:321–335, 1982.

580. Paulson OB: Regional cerebral blood flow in apoplexy due to occlusion of the middle cerebral artery. Neurology 20:63–77, 1970.

581. Agnoli A, Fieschi C, Bozzao L, et al: Autoregulation of cerebral blood flow. Studies during drug-induced hypertension in normal subjects and in patients with cerebral vascular diseases. Circulation 38:800–812, 1968.

582. Fieschi C, Agnoli A, Prencipe M, et al: Impairment of the regional vasomotor response of cerebral vessels to hypercarbia in vascular diseases. Eur Neurol 2:13–30, 1969.

583. Olsen TS: Regional cerebral blood flow after occlusion of the middle cerebral artery. Acta Neurol Scand 73:321–337, 1986.

584. Ballotta E, Da Giau G, Baracchini C, et al: Early versus delayed carotid endarterectomy after a non-disabling ischemic stroke: A prospective, randomized study. Surgery 131:287–293, 2002.

585. Finnerty FA, Witkin L, Fazekas JF: Cerebral hemodynamics during cerebral ischemia induced by acute hypotension. J Clin Invest 33:1227–1232, 1954.

586. Njemanze PC: Critical limits of pressure-flow relation in the human brain. Stroke 23:1743–1747, 1992.

587. Vorstrup S, Barry DI, Jarden JO, et al: Chronic antihypertensive treatment in the rat reverses hypertension-induced changes in cerebral blood flow autoregulation. Stroke 15:312–318, 1984.

588. Toyoda K, Fujii K, Ibayashi S, et al: Attenuation and recovery of brain stem autoregulation in spontaneously hypertensive rats. J Cereb Blood Flow Metab 18:305–310, 1998.

589. Paulson OB, Vorstrup S, Anderson AR, et al: Converting enzyme inhibition resets cerebral autoregulation at lower blood pressure. J Hypertens 3:S487-S488, 1985.

590. Arbit E, DiResta GR, Bedford RF, et al: Intraoperative measurement of cerebral and tumor blood flow with laser-Doppler flowmetry. Neurosurgery 24:166–170, 1989.

591. Schregel W, Geibler C, Winking M, et al: Transcranial Doppler monitoring during induction of anesthesia: Effects of propofol, thiopental, and hyperventilation in patients with large malignant brain tumors. J Neurosurg Anesthesiol 5:86–93, 1993.

592. Shin JH, Lee HK, Kwun BD, et al: Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: Preliminary results. AJR Am J Roentgenol 179:783–789, 2002.

593. Bedford RF, Morris L, Jane JA: Intracranial hypertension during surgery for supratentorial tumor: Correlation with preoperative computed tomography scans. Anesth Analg 61:430–433, 1982.

594. Yeung WTI, Lee T-Y, Maestro RFD, et al: Effect of steroids on iopamidol blood-brain transfer constant and plasma volume in brain tumors measured with X-ray computed tomography. J Neuro-oncology 18:53–60, 1994.

595. Van Roost D, Hartmann A, Quade G: Changes of cerebral blood flow following dexamethasone treatment in brain tumour patients. Acta Neurochir (Wien) 143:37–43, 2001.

596. Jarden JO, Dhawan V, Moeller JR, et al: The time course of steroid action on blood-to-brain and blood-to-tumor transport of 82 Rb: A positron emission tomographic study. Ann Neurol 25:239–245, 1989.

597. Wasterlain CG: Mortality and morbidity from serial seizures: An experimental study. Epilepsia 15:155–176, 1974.


858

Previous Next